Order Article Reprints

Gondois-Rey F, Paul M, Alcaraz F, Bourass S, Monnier J, Malissen N, Grob J-J, Bruger AM, Van Der Bruggen P, Gaudy-Marqueste C, et al. Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma. Cancers. 2021; 13(6):1362. https://doi.org/10.3390/cancers13061362

Gondois-Rey, Françoise, Magali Paul, Florence Alcaraz, Sarah Bourass, Jilliana Monnier, Nausicaa Malissen, Jean-Jacques Grob, Annika M. Bruger, Pierre Van Der Bruggen, Caroline Gaudy-Marqueste, and et al. 2021. "Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma" Cancers 13, no. 6: 1362. https://doi.org/10.3390/cancers13061362

Gondois-Rey, F., Paul, M., Alcaraz, F., Bourass, S., Monnier, J., Malissen, N., Grob, J.-J., Bruger, A. M., Van Der Bruggen, P., Gaudy-Marqueste, C., & Olive, D. (2021). Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma. Cancers, 13(6), 1362. https://doi.org/10.3390/cancers13061362